VRTX
VRTX
US92532F1003
Vertex Pharmaceuticals Incorpor
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 12.001.300.000 11.020.100.000
8.9%
Cost of Revenue 1.651.300.000 1.530.500.000
7.9%
Gross Profit 10.350.000.000 9.489.600.000
9.1%
5.795.600.000 9.723.000.000
40.4%
Operating Income 4.554.400.000 -233.400.000
2051.3%
Pretax Income 4.643.200.000 248.500.000
1768.5%
Net Income Common Stockholders 3.953.200.000 -535.600.000
838.1%
-- --
--
-- --
--
ende